Ezetimibe (Ohm Laboratories Inc.)
Welcome to the PulseAid listing for the Ezetimibe drug offered from Ohm Laboratories Inc.. This Decreased Cholesterol Absorption [PE],Dietary Cholesterol Absorption Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Ohm Laboratories Inc. |
NON-PROPRIETARY NAME: | Ezetimibe |
SUBSTANCE NAME: | EZETIMIBE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Decreased Cholesterol Absorption [PE],Dietary Cholesterol Absorption Inhibitor [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-06-12 |
END MARKETING DATE: | 0000-00-00 |
Ezetimibe HUMAN PRESCRIPTION DRUG Details:
Item Description | Ezetimibe from Ohm Laboratories Inc. |
LABELER NAME: | Ohm Laboratories Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/1) |
START MARKETING DATE: | 2017-06-12 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 51660-200_816c4383-e3e9-4cd3-9ab0-5789b8c9d167 |
PRODUCT NDC: | 51660-200 |
APPLICATION NUMBER: | ANDA207311 |
Other EZETIMIBE Pharmaceutical Manufacturers / Labelers: